← Leaderboards
Sheila Therese Angeles-Han
Cincinnati Childrens Hosp Med Ctr
$6,009,808
Attributed
$6,009,808
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,009,808 · 3
By mechanism
R01$5,029,818 · 2
K23$979,990 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Jose A. Cancelas$9,659,208
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryPreventRheumatologyChildMonitorBlindnessOphthalmologyProspectiveRisk FactorsVisionDiagnosisUveitisEye DiseasesCellsChildhoodChronic Childhood ArthritisEarly DiagnosisAlgorithmsAntinuclear AntibodiesAffectPathogenesisGenetic Risk FactorMeasurementCohort
Grant awards (14)
Optimizing methotrexate use for the management of chronic pediatric non-infectious uveitis$560,861
R01 · FY2025 · EY · contact PI
Optimizing methotrexate use for the management of chronic pediatric non-infectious uveitis$591,273
R01 · FY2024 · EY · contact PI
Optimizing methotrexate use for the management of chronic pediatric non-infectious uveitis$657,498
R01 · FY2023 · EY · contact PI
Predicting uveitis onset in children with juvenile idiopathic arthritis$625,855
R01 · FY2023 · EY · contact PI
Predicting uveitis onset in children with juvenile idiopathic arthritis$618,966
R01 · FY2022 · EY · contact PI
Predicting uveitis onset in children with juvenile idiopathic arthritis$618,966
R01 · FY2021 · EY · contact PI
Predicting uveitis onset in children with juvenile idiopathic arthritis$666,314
R01 · FY2020 · EY · contact PI
Predicting uveitis onset in children with juvenile idiopathic arthritis$690,085
R01 · FY2019 · EY · contact PI
Outcomes of children with juvenile idiopathic arthritis-associated uveitis$147,570
K23 · FY2015 · EY · contact PI
Outcomes of children with juvenile idiopathic arthritis-associated uveitis$48,428
K23 · FY2015 · EY · contact PI
Outcomes of children with juvenile idiopathic arthritis-associated uveitis$195,998
K23 · FY2014 · EY · contact PI
Outcomes of children with juvenile idiopathic arthritis-associated uveitis$195,998
K23 · FY2013 · EY · contact PI
Outcomes of children with juvenile idiopathic arthritis-associated uveitis$195,998
K23 · FY2012 · EY · contact PI
Outcomes of children with juvenile idiopathic arthritis-associated uveitis$195,998
K23 · FY2011 · EY · contact PI